We furthermore observed frequent alterations in the MAPK pathway in 80% of EATL-II cases, including TP53 (33%), BRAF (26%), KRAS (20%) and NRAS mutations which were essentially mutually exclusive. The gene discussed is BRAF; the disease is enteropathy-associated T-cell lymphoma.